Activities of daily living

Sinaptica Therapeutics Announces Publication of Positive Results from Phase II Trial Evaluating the Potential of Precision-Delivered Noninvasive Neurostimulation Treatment for Mild-to-Moderate Alzheimer’s Disease

Retrieved on: 
Tuesday, October 25, 2022

CAMBRIDGE, Mass., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized electromagnetic therapeutics to treat neurodegenerative diseases, today announced the publication of a Phase II trial conducted independently under the leadership of its co-founders, which yielded positive results demonstrating that precision-delivered noninvasive brain stimulation has the potential to slow the progression of cognitive and functional decline in patients with mild-to-moderate dementia due to Alzheimer’s disease. The findings have been published in the peer-reviewed neurology journal Brain.

Key Points: 
  • Fifty patients were enrolled in the Phase II randomized, double-blind, sham-controlled trial.
  • Treatment was well tolerated, and no serious adverse events were observed in patients treated with rTMS for 6 months.
  • These unprecedented peer-reviewed clinical results demonstrate the potential for this new class of personalized electromagnetic therapeutics to treat cognitive and functional decline safely and noninvasively in Alzheimers disease patients.
  • Sinaptica Therapeutics is a clinical-stage electromagnetic therapeutics company pioneering a personalized noninvasive brain stimulation approach with the potential to revolutionize the treatment of Alzheimers disease (AD).

Poets&Quants™ Reveals the Top 12 Finalists in Inaugural Pitch Competition in Partnership with Olin Business School at Washington University of St. Louis

Retrieved on: 
Tuesday, February 15, 2022

The contest was open to all current undergraduate and graduate school students or any prospect interested in a graduate business school degree.

Key Points: 
  • The contest was open to all current undergraduate and graduate school students or any prospect interested in a graduate business school degree.
  • These finalists will now compete for three slots to present in person on Washington University's campus in St. Louis in early March.
  • The winner, to be chosen by a panel of judges, will receive $50,000 in funding from the Olin School.
  • About Olin Business School at Washington University in St. Louis
    Firmly established at the Gateway to the West, Olin Business School at Washington University in St. Louis stands as the gateway to something far grander.

Caregivers Helping Caregivers: New Web Resource for Helping a Loved One with Day-to-Day Activities

Retrieved on: 
Wednesday, August 4, 2021

When you add in helping their loved one with many of their day-to-day activities, it can become overwhelming.

Key Points: 
  • When you add in helping their loved one with many of their day-to-day activities, it can become overwhelming.
  • Most family caregivers need to assist their loved ones with activities of daily living (ADLs)eating, bathing/showering, dressing, mobility, and using the toilet.
  • For someone caring for a loved one with Alzheimers disease or other forms of dementia, assisting with these types of activities may be happening more often.
  • Caregivers have an opportunity to share their own story and how they have managed these day-to-day activities.

AC Immune Reports Top Line Results from TAURIEL Phase 2 Trial Evaluating Semorinemab in Early Alzheimer’s Disease

Retrieved on: 
Wednesday, September 23, 2020

Two secondary endpoints, Alzheimers Disease Assessment Scale-Cognitive Subscale 13 (ADAS-Cog13) and Alzheimers Disease Cooperative Study Group Activities of Daily Living Inventory (ADCS-ADL) were also not met.

Key Points: 
  • Two secondary endpoints, Alzheimers Disease Assessment Scale-Cognitive Subscale 13 (ADAS-Cog13) and Alzheimers Disease Cooperative Study Group Activities of Daily Living Inventory (ADCS-ADL) were also not met.
  • Additional data analyses are ongoing and Genentech plans to present the results from TAURIEL at an upcoming medical congress.
  • The Phase 2 TAURIEL study of semorinemab is a 73-week, double-blind, placebo-controlled trial to determine if it can slow the rate of clinical decline in early (prodromal to mild) AD.
  • Two secondary endpoints, Alzheimers Disease Assessment Scale-Cognitive Subscale 13 (ADAS-Cog13) and Alzheimers Disease Cooperative Study Group Activities of Daily Living Inventory (ADCS-ADL) also were not met.

Senior Home Care Helps Keep Seniors Safe and Reduces the Spread of the Virus

Retrieved on: 
Wednesday, May 27, 2020

In this way, they are able to meet any schedule needs including part-time care, full-time care, live-in care, temporary care, permanent care and care 24 hours per day, seven days per week.

Key Points: 
  • In this way, they are able to meet any schedule needs including part-time care, full-time care, live-in care, temporary care, permanent care and care 24 hours per day, seven days per week.
  • "Keeping seniors safe, healthy, comfortable and happy has always been a cornerstone of our mission at The Senior Company.
  • The Senior Company provides Personal Care as well as Skilled Nursing Care services that are available to help seniors and families who are in need of assistance with activities of daily living.
  • Some of these "ADLs" include bathing, toileting, dressing, light housekeeping, meal preparation, errands, hospice care and other personalized hourly or live-in home care services.

New, Interactive E-Catalog Provides Easy Access to Innovative Products and Solutions for Daily Living

Retrieved on: 
Thursday, June 6, 2019

"The new format is easy to digitally share or download, making it a valuable resource for end users and health professionals alike."

Key Points: 
  • "The new format is easy to digitally share or download, making it a valuable resource for end users and health professionals alike."
  • Featuring a wide assortment of over 400 daily living aids, the catalog is comprised of 16 different categories for activities of daily living; including bath safety, personal care, eating/drinking, and more.
  • Visit http://www.maddak.com/ecatalogs to access the new interactive e-catalog and discover SP Ableware Maddak's innovative products for independent living.
  • SP Ableware - Maddak manufactures products that simplify the tasks of daily living -eating, drinking, dressing, grooming, bathing, toileting, etcetera- for seniors, people with disabilities, and people undergoing rehabilitation.

Bridging the Gap Therapy Solutions Sees Cause For Concern For Florida Special Needs Children and Families

Retrieved on: 
Thursday, April 4, 2019

These Medicaid pay cuts will dramatically effect programs and resources for special needs children and their families.

Key Points: 
  • These Medicaid pay cuts will dramatically effect programs and resources for special needs children and their families.
  • The science has been shown to increase clients functional communication ability, social skills, daily living skills (feeding, toileting, dressing, etc.)
  • "The proposed pay cut will cause clinics to lose Registered Behavior Technician (RBT's)," said Lindsey Meyer, Board Certified Behavior Analyst (BCBA), Bridging the Gap Therapy Solutions of Land O' Lakes, FL.
  • "The RBT's are essential to the hours of service and intensive therapy we are able to provide children and their families.